| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MDAI | Common Stock, par value $0.0001 per share | Purchase | $5.97K | +1K | +0.04% | $5.97 | 2.48M | Sep 12, 2023 | See Footnotes | F1, F4, F5, F6 |
| transaction | MDAI | Common Stock, par value $0.0001 per share | Purchase | $1K | +198 | +0.01% | $5.07 | 2.48M | Sep 13, 2023 | See Footnotes | F2, F4, F5, F6 |
| transaction | MDAI | Common Stock, par value $0.0001 per share | Purchase | $998 | +355 | +0.01% | $2.81 | 2.48M | Nov 14, 2023 | See Footnotes | F3, F4, F5, F6 |
| transaction | MDAI | Common Stock, par value $0.0001 per share | Purchase | $1.34K | +500 | +0.02% | $2.68 | 2.48M | Nov 16, 2023 | See Footnotes | F4, F5, F6 |
| transaction | MDAI | Common Stock, par value $0.0001 per share | Purchase | $5.34K | +2K | +0.08% | $2.67 | 2.48M | Nov 20, 2023 | See Footnotes | F5, F6 |
| Id | Content |
|---|---|
| F1 | The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $5.94 to $6.00, inclusive. Dr. John Michael DiMaio (the "Reporting Person") undertakes to provide to the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares acquired in the trades at each separate price within the range set forth in this footnote. |
| F2 | The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $5.02 to $5.14, inclusive. The Reporting Person undertakes to provide to issuer, any security holder of the issuer or the staff of the SEC, upon request, full information regarding the number of shares acquired in the trades at each separate price within the range set forth in this footnote. |
| F3 | The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $2.81 to $2.82, inclusive. The Reporting Person undertakes to provide to issuer, any security holder of the issuer or the staff of the SEC, upon request, full information regarding the number of shares acquired in the trades at each separate price within the range set forth in this footnote. |
| F4 | This transaction represents a de minimis acquisition of securities by the Reporting Person under Section 240.16a-6 of the Securities Exchange Act of 1934, as amended (the "Act"), which, in the aggregate with certain other transactions within a six-month period, does not exceed $10,000 in market value. |
| F5 | This statement is filed by and on behalf of the Reporting Person. The Reporting Person is the record and direct beneficial owner of the securities covered by this statement. |
| F6 | The Reporting Person may be deemed to be a member of a group with respect to the issuer or securities of the issuer for purposes of Section 13(d) or 13(g) of the Act. The Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that the Reporting Person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer. |